Humacyte Q2 Operating Expenses USD 27.402 Million
HUMA•Q2 financial results
Aug. 12 (Reuters) - Humacyte Q2 net income USD -36.802 million vs. IBES estimate USD -22.8 million.
- Q2 basic EPS USD -0.16
- Q2 operating income USD -26.996 million vs. IBES estimate USD -22.1 million




